leadf
logo-loader
AIM:AGY FRA:HHU

Allergy Therapeutics PLC

 Receive alerts
Market:
AIM
Market Cap:
£127.2 m
Price
19.85 GBX
Change
-3.17%
52 weeks high
22.00
52 weeks low
7.00
07.02

Director Interviews

In brief

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

In brief Deep dive Research Latest news Insight Interviews

Deep dive We explore the investor case for growth companies

Allergy Therapeutics looks forward to key hay fever trial
Allergy Therapeutics PLC -

Snapshot

  • Profitable allergy specialist developing new inoculations
  • Strong revenue growth in Europe
  • Long pipeline of new products under development
Open Deep dive

Latest news

Allergy Therapeutics makes strong start to financial year unimpeded by...

1 day, 4 hours ago

Allergy Therapeutics sees record cash balance as interim sales rise 7%

on 13/1/21

Allergy Therapeutics says peanut allergy biomarker study gets underway

on 5/1/21

Allergy Therapeutics says patient screening for exploratory field study of...

on 26/10/20

Allergy Therapeutics sees growth across Europe as new trials approach

on 23/9/20

Allergy Therapeutics broadens its collaboration with vaccine pair in a deal...

on 3/9/20

Allergy Therapeutics earnings to exceed expectations after a strong year

on 15/7/20

Allergy Therapeutics allowed to hit the reset button on birch pollen phase...

on 9/7/20

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Allergy Therapeutics PLC -
Allergy Therapeutics gets big forecast upgrade from finncap after trading update

The broker now expects profits to around £5m higher than its previous forecasts at £2.9m.

on 24/6/20

Watch

Allergy Therapeutics PLC - Allergy Therapeutics reveal 'remarkable' growth given 'challenges circumstances' of Brexit and Covid Director Interviews Allergy Therapeutics reveal 'remarkable' growth given 'challenges circumstances' of Brexit and Covid
1 day, 2 hours ago
PZ Cussons - Market report: Weaker pound steers FTSE higher, while Tesla drives investors away Mid caps Market report: Weaker pound steers FTSE higher, while Tesla drives investors away
on 23/9/20
Allergy Therapeutics PLC - Allergy Therapeutics is 'firing on all cylinders' with strong cash position in full year results Small caps Allergy Therapeutics is 'firing on all cylinders' with strong cash position in full year results
on 23/9/20
Allergy Therapeutics PLC - Allergy Therapeutics on the potential of peanut vaccine Director Interviews Allergy Therapeutics on the potential of peanut vaccine
on 3/3/20
View all